Background Image
Table of Contents Table of Contents
Previous Page  51 / 66 Next Page
Information
Show Menu
Previous Page 51 / 66 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 32, No 3, May/June 2021

AFRICA

161

PASCAR and WHF Cardiovascular Diseases Scorecard

project

Lilian Mbau, Jean M Fourie, Wihan Scholtz, Oana Scarlatescu, George Nel,Gladwell Gathecha

Abstract

Data collected for the World Heart Federation’s Scorecard

project regarding the current state of cardiovascular disease

prevention, control and management, along with related non-

communicable diseases in Kenya are presented. Furthermore,

the strengths, threats, weaknesses and priorities identified

from these data are highlighted in concurrence with relat-

ed sections in the accompanying infographic. Information

was collected using open-source data sets from the World

Bank, the World Health Organization, the Institute for

Health Metrics and Evaluation, the International Diabetes

Federation and relevant government publications.

Cardiovasc J Afr

2021;

32

: 161–167

DOI: 10.5830/CVJA-2021-022

Onbehalf of theWorldHeartFederation (WHF), thePan-African

Society of Cardiology (PASCAR) co-ordinated data collection

and reporting for the country-level Cardiovascular Diseases

Scorecard to be used in Africa.

1-4

In 2018, Kenya participated in

the pilot study to develop the scorecard that was used to inform

some of the discussions at the roundtable held together with the

Kenya Cardiac Society (KCS) (OS, pers commun). Therefore,

it was decided to include Kenya’s data within the present

project, which were updated with assistance from the KCS and

Ministry of Health (MoH). In this report, we summarise Kenya’s

strengths, threats, weaknesses and priorities identified from the

collected data, along with needs to be considered in conjunction

with the associated sections in the accompanying infographic.

Data sets that were used included open-source data from the

World Bank, the World Health Organization (WHO), Institute

for Health Metrics and Evaluation, the International Diabetes

Federation (IDF) and government publications.

Part A: Demographics

Kenya is a lower-middle income country, as indicated by the

World Bank (2018), with 72.5% of its people living in rural

areas.

5

In 2015, about 37% of the population was living below

the US$1.9-a-day ratio. Life expectancy at birth in 2019 was

64 and 69 years for men and women, respectively.

5

The general

government health expenditure was 2.1% of the gross domestic

product (GDP), while the country’s GDP per capita was

US$1 816.5 in 2019.

5,6

Part B: National cardiovascular disease

epidemic

The national burden of cardiovascular diseases and

non-communicable disease risk factors

Kenya had a premature (30–70 years old) cardiovascular disease

(CVD) mortality rate of 8%, while the total CVD mortality rate

was 13.8% in 2019.

7

The percentage of disability-adjusted life

years (DALYs) resulting from CVD was 6.3%. The prevalence

of atrial fibrillation (AF) and atrial flutter was 0.1%, while that

of rheumatic heart disease (RHD) was 1.2%.

7

The total RHD

mortality rate was 0.14% of all deaths (Table 1).

7

Tobacco and alcohol

The prevalence of tobacco use in adult men 15 years and older

was 18.8% in 2018, while adult women (2.3%) hardly smoked.

6

However, STEPS (Step-wise survey for NCD risk factors) data

reported in 2015 indicated 23% of Kenyan men and 4.1% of

women aged 18–69 years used tobacco.

8

Data available for the

young smokers, 13–15 years old, revealed 12.8 and 6.7% of boys

and girls, respectively, smoked tobacco in

2013

.

9

The estimated

annual direct cost of tobacco use was not available. The

premature CVD mortality rate attributable to tobacco is 2% of

the total deaths, which is much lower than the global 10%.

10

The

three-year (2016–18) average recorded alcohol consumption

per capita (≥ 15 years) was 1.7 litres, which is lower than most

neighbouring countries, except Ethiopia with 0.9 litres (Table

1).

6

Kenya Cardiac Society, Nairobi, Kenya

Lilian Mbau, MB ChB, MPH, PgDip (Diab)

Pan-African Society of Cardiology, Cape Town, South Africa

Jean M Fourie, MPhil

Wihan Scholtz, MSc,

wihan@medsoc.co.za

George Nel, MSc

World Heart Federation, Geneva, Switzerland

Oana Scarlatescu, MA

Department of Non-Communicable Diseases, Ministry of

Health, Nairobi, Kenya

Gladwell Gathecha, BDS, MSc

Kenya Country Report